Insights into the mechanism of onabotulinumtoxinA in chronic migraine. - Wikidata - awgldk - TriplyDB

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

http://www.wikidata.org/entity/Q35837340

about

An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection Therapeutic applications of botulinum neurotoxins in head and neck disorders Targeted Peripheral Nerve-directed Onabotulinumtoxin A Injection for Effective Long-term Therapy for Migraine Headache OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients OnabotulinumtoxinA for chronic migraine: a critical appraisal.Effects of OnabotulintoxinA on Habituation of Laser Evoked Responses in Chronic Migraine Reduction in Bladder-Related Autonomic Dysreflexia after OnabotulinumtoxinA Treatment in Spinal Cord Injury.Effective Botulinum Toxin Injection Guide for Treatment of Temporal Headache.Time course analysis of the effects of botulinum neurotoxin type A on pain and vasomotor responses evoked by glutamate injection into human temporalis muscles.OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.Biomarkers associated with migraine and their potential role in migraine management.Emerging therapies for chronic migraine.Glutamate receptor antagonists in the management of migraine.OnabotulinumtoxinA Injections for the Treatment of Cyclic Vomiting Syndrome.The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review.An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.Botulinum Toxin for the Treatment of Neuropathic Pain.Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study Update on Medication-Overuse Headache and Its Treatment.OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder.Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine.Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis

P2860

Q24609746-BF2766EB-BBE3-41F1-97FD-6B0B0E6D1850 Q26799317-617378CB-E2B9-48B7-8A24-DF584AD523C1 Q27024303-D67C6A96-F6A7-4F8C-A5EE-7BDFDABB48D3 Q30846954-E11D1D60-585E-4B70-A48A-C18D034B0F69 Q35266832-7B86EBC0-95AF-42D0-A171-4D3A362DC40F Q35822040-4C5A3FC7-B623-4764-ABB2-1E9B581C6648 Q36032213-70AA895D-55FD-4882-AB66-29311EBD521E Q37281359-E34E8884-4831-4523-9E91-A50697A8276F Q37285681-2D93ABE4-D6E1-49B3-9ECB-9C1B6FBB4F7F Q37617800-C1177497-3587-4893-89B7-FD49B13CB9FA Q37999053-D870097D-83B6-4F51-B9C8-DA58FB39F1B5 Q38121110-EB1D0657-132E-4076-BF84-B8BF389466FA Q38187606-82006EF4-57D1-4F06-80E9-827B6B900B5E Q38230246-0690967B-74CC-4FC1-9891-8997D22F098B Q38396223-BDC0BA80-C88C-43EB-ADAA-D77F16F27D99 Q39145962-8F9FCF57-D906-420C-8ECC-782788F878CC Q39218587-A6A6F002-77B3-4650-8455-3030791ABE9D Q41669358-74227544-28C9-417A-8E7C-DCDE2733C207 Q42203910-857D17AE-E58C-48AB-95C4-242BD842083E Q47635235-9029EFFA-FBE0-48F7-BF3A-559AB2B364E1 Q48418075-68C09020-B113-4B31-A055-9DB4DBC64F17 Q51099895-A1F80DD8-BCBF-4C70-9826-53E35FDE417F Q55515282-F21C7B01-A151-4F94-B1FF-7BDA8599D9F5 Q57815499-10C5B85B-FC8A-47BA-8F12-2CF9821EDE70

P2860

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

http://www.wikidata.org/entity/Q35837340

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

@ast

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

@en

type

label

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

@ast

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

@en

prefLabel

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

@ast

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

@en

P1433

Q35837340-EE1F6DF8-CD89-4625-AF45-E4F701D51F61

P1476

Q35837340-016443F9-581C-40A9-961F-6CB72D71623F

P2093

Q35837340-09924EE2-DF45-4D52-A6E8-94CB726738A2

Q35837340-DA11264F-E6E8-4B3D-9D98-75696DCA1A40

P2860

Q35837340-06356639-E0D2-418E-9D54-ED449A2B137B

Q35837340-0FCEF5A0-96FF-474B-B074-648DED08C8D8

Q35837340-124FE3DB-1E3F-41C1-AADD-D105F81A88E9

Q35837340-13DDD2A5-2BA2-48AF-B5A1-64DE7FCA4869

Q35837340-145D5E88-439F-46AB-8B8D-A0D5A702671C

Q35837340-1AE3FAAA-2988-4E03-A3D9-952A54F0146A

Q35837340-2B2AB239-5DF7-4F2A-96F3-082640958EBD

Q35837340-2CD49AFC-0316-44C4-9B1E-3960849FE47A

Q35837340-2D1138D7-0E85-489F-BB40-5A807F41D533

Q35837340-2E84BA7C-9D44-4337-B073-9062DA212972

P304

Q35837340-AB43FD91-D7EA-4CDD-8AF7-4771B293CD36

P31

Q35837340-4241FA13-6D73-4420-BE2C-78F580F28924

P356

Q35837340-DC23FCB0-DE5E-40B9-B58C-66DFDFBBF724

P433

Q35837340-5251344E-348D-4A5E-B837-61EDEA29745D

P478

Q35837340-BF6FAA7A-DFAC-49D9-BD3E-812C46214CD0

P577

Q35837340-091E8997-BF29-4860-BB55-F7B3C7E4E8C8

P5875

Q35837340-9D62E6FB-D022-467C-B4F9-57D573B1AC1C

P698

Q35837340-B8DF8D6E-A495-42A4-B138-430A8D0B7CF5

P921

Q35837340-A12C367A-371B-49BA-9881-6CC3AD102C98

P932

Q35837340-E6B95539-69EB-4FB6-92B1-9AABC626A90B

P356

J.1526-4610.2011.02022.X

P1433

P1476

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

@en

P2093

Paul L Durham

http://www.w3.org/2001/XMLSchema#string

Roger Cady

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

Oligodendrocytes: biology and pathology

Pressure pain sensitivity maps of the neck-shoulder and the low back regions in men and women.

Neural mechanisms and pathways in craniofacial pain.

Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates.

How botulinum and tetanus neurotoxins block neurotransmitter release.

A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.

Action potential modulates Ca2+-dependent and Ca2+-independent secretion in a sensory neuron

Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.

Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach.

P304

1573-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1526-4610.2011.02022.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51797356

http://www.w3.org/2001/XMLSchema#string

P698

22082429

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

3306767

http://www.w3.org/2001/XMLSchema#string